Showing results (1831-1840 of 3,529) with videos related to
Sort By:
Pageof 353
Thoracic Cancer|May 4, 2021
Survival benefits of salvage surgery for primary lung cancer based on routine clinical practiceKatsutoshi Adachi, Hiroaki Kuroda, Masayuki Tanahashi, et al.Thoracic Cancer|May 4, 2021
Role of chemotherapy after curative esophagectomy in squamous cell carcinoma of the thoracic esophagus: A propensity score-matched analysisKai Zhu, Peng Ren, Yueyang Yang, et al.Thoracic Cancer|May 4, 2021
Analysis of clinicopathological features of primary diaphragm tumors: A single-center studyChao Guo, Lei Liu, Jiaqi Zhang, et al.Thoracic Cancer|May 14, 2021
Impact of concomitant medication on clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A retrospective studyKaho Miura, Yoshiyuki Sano, Seiji Niho, et al.Thoracic Cancer|May 5, 2021
Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysisChen Li, Lijun Tan, Xiao Liu, et al.Thoracic Cancer|May 5, 2021
Large pulmonary sclerosing pneumocytoma in a young female: A rare lung tumorDo Kyun Kang, Min Kyun Kang, Woon Heo, et al.Thoracic Cancer|May 11, 2021
Using a risk model for probability of cancer in pulmonary nodulesSi-Qi Liu, Xiao-Bin Ma, Wan-Mei Song, et al.Thoracic Cancer|May 13, 2021
Potential role for the tumor suppressor CYLD in brain and notochord developmentTe Li, Yiyan Wang, Dengwen Li, et al.Thoracic Cancer|April 16, 2020
Mutational landscape and characteristics of ERBB2 in non-small cell lung cancerXue-Wu Wei, Xin Gao, Xu-Chao Zhang, et al.Thoracic Cancer|May 21, 2020
Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer without harboring EGFR T790M mutationZengzhi Lian, Wenwen Du, Yang Zhang, et al.Pageof 353